Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bionano Genomics Inc (NQ: BNGO )

1.140 +0.060 (+5.56%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,272,964
Open 1.090
Bid (Size) 1.110 (1)
Ask (Size) 1.140 (1)
Prev. Close 1.080
Today's Range 1.090 - 1.170
52wk Range 1.060 - 4.350
Shares Outstanding 279,140,015
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Buy This Magnificent Growth Stock Before It's Too Late
Bionano is gaining momentum and could soon be approaching escape velocity. 
Via The Motley Fool
Is Bionano Genomics a Risk Worth Taking at This Price?
Revenues are increasing, but with its meme stock heyday well in the rearview mirror, it's fair to ask whether Bionano Genomics stock is a risk worth taking 
Via MarketBeat

Performance

YTD
-20.83%
-20.83%
1 Month
-17.39%
-17.39%
3 Month
-30.91%
-30.91%
6 Month
-46.48%
-46.48%
1 Year
-50.00%
-50.00%

More News

Read More
Stocks React To February Jobs Report: The Winners And Losers
Via Benzinga
Bionano Genomics (BNGO) Q4 2022 Earnings Call Transcript
Via The Motley Fool
Earnings Preview: Bionano Genomics
Via Benzinga
Is Bionano Genomics Stock a Buy Now?
Via The Motley Fool
BioNano Genomics Reports Q4 Beat, Issues FY23 Guidance: What Investors Need To Know
Via Benzinga
This Growth Stock Is Down 38% and Wall Street Says It's Worth Buying Hand Over Fist
Via The Motley Fool
7 Stocks to Buy on Weakness While You Can
Via InvestorPlace
Get Ready to Soar: 2 High-Octane Growth Stocks Wall Street Expects to Climb in 2023
Via The Motley Fool
Why Bionano Genomics, Pacific Biosciences of California, and Sangamo Therapeutics Stocks Crumbled This Week
Via The Motley Fool
3 Under-the-Radar Stocks With 590% to 772% Upside in 2023, According to Wall Street
Via The Motley Fool
NVIDIA Outlook Improving: Watchlist Candidate for 2023
Via MarketBeat
Topics Economy
Exposures Supply Chain
Dear JAGX Stock Fans, Mark Your Calendars for Jan. 12
Via InvestorPlace
Why Is Biora Therapeutics (BIOR) Stock Up 12% Today?
Via InvestorPlace
Bionano Genomics (BNGO) Stock Pops on Promising Publication
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Via Benzinga
The Top 7 Stocks to Watch in 2023
Via InvestorPlace
This Innovative Growth Stock Could Double or More in 2023
Via The Motley Fool
7 Drug Stocks That Will Soar in 2023
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Adobe Shares Are Trading Higher; Here Are 31 Stocks Moving Premarket
Via Benzinga
Guardant Health, Novavax And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
Why MEI Pharma Shares Are Trading Lower By Around 35%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Summit Therapeutics Shares Are Trading Higher By Over 82%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.